AIFF · Firefly Neuroscience, Inc. · Executive Compensation
$1.15
-0.04 (-3.36%)
At close · Oct 12
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Notwithstanding the Company's cash on hand as of June 30, 2026, the Company's recurring losses, negative cash flows from operating activities, and revenue that remains insufficient to cover operating costs raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued. Because critical elements of these plans are not within management's control, management does not consider them probable of being effectively implemented such that they would alleviate the substantial doubt described above. Accordingly, management has concluded that substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued has not been alleviated.”View the 10-Q filed Aug 11, 2026
Market Cap
$18.28M
Shares
15.69M
Volume · Oct 12
123.94K
Avg daily vol (3M)
2.64M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Greg Lipschitz | Chief Executive Officer | $1,063,718 |
| David DeCaprio | President and Chief Operating Officer | $748,335 |
| Gil Issachar | Former Chief Technology Officer | $258,986 |
| Paul Krzywicki | Chief Financial Officer | $225,204 |
| Jon Olsen | Former Chief Executive Officer | $44,908 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Gil Issachar | Chief Technology Officer | $803,967 |
| Jon Olsen | Former Chief Executive Officer | $742,968 |
| Greg Lipschitz | — | $262,119 |
| Paul Krzywicki | Chief Financial Officer | $154,962 |
| Samer Kaba | Former Chief Medical Officer | $139,515 |
| Dave Johnson | Former Executive Chairman | $72,500 |
| Scott Reeves | — | $34,950 |
| Stephen Purcell | Former Chief Financial Officer | $16,497 |
| Brian Posner | — | — |
| David DeCaprio | — | — |
| Stella Vnook | — | — |
| Arun Menawat | — | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Gil Issachar | Chief Technology Officer | $192,869 |
| Jon Olsen | Former Chief Executive Officer | $168,380 |
| Stephen Purcell | Former Chief Financial Officer | $121,184 |
| Brian Posner | — | — |
| Stella Vnook | — | — |
| Arun Menawat | — | — |
| Greg Lipschitz | — | — |
| David DeCaprio | — | — |
| Scott Reeves | — | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Timothy G. Hannon | Chief Financial Officer | $792,413 |
| Jon Olsen | Chief Executive Officer | $414,042 |
| G. James Benoit | Chief Executive Officer | $299,192 |
| Stephen Purcell | Former Chief Financial Officer | $268,350 |
| Stella Vnook | — | — |
| Brian Posner | — | — |
| Greg Lipschitz | — | — |
| Scott Reeves | — | — |
| David DeCaprio | — | — |
| Arun Menawat | — | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| G. James Benoit | Chief Executive Officer | $1,648,133 |
| Stanley A. Reese | Chief Executive Officer from January 1, 2021 through August 26, 2021 | $336,928 |
| Matthew T. Sands | Chief Financial Officer from April 22, 2020 through September 29, 2021 | $201,378 |
| Timothy G. Hannon | Chief Financial Officer | $86,136 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Stanley A. Reese | Chief Executive Officer from January 1, 2021 through August 26, 2021 | $230,852 |
| Matthew T. Sands | Chief Financial Officer from April 22, 2020 through September 29, 2021 | $190,851 |
| G. James Benoit | Chief Executive Officer | — |
| Timothy G. Hannon | Chief Financial Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jessica Paz | Chief Accounting Officer | Appointed | 2026-09-14 |
| Paul Krzywicki | Chief Financial Officer | Terminated | 2026-09-14 |
| Arun Menawat | Class III director | Appointed | 2026-08-07 |
| Gil Issachar | Head of AI and Neuroscience | Appointed | 2026-06-22 |
| Arun Menawat | chairperson and member of the Compensation Committee, member of the Audit Committee, and member of the Nominating and Corporate | Appointed | 2025-04-24 |
| David DeCaprio | chairperson and member of the Compensation Committee, member of the Audit Committee, and member of the Nominating and Corporate | Resigned | 2025-04-24 |
| David DeCaprio | President and Chief Operating Officer | Appointed | 2025-04-24 |
| Greg Lipschitz | Chief Executive Officer | Appointed | 2025-04-01 |
| Arun Menawat | Chairman | Appointed | 2025-03-12 |
| Greg Lipschitz | Executive Chairman | Resigned | 2025-03-12 |
| Greg Lipschitz | Interim Chief Executive Officer | Appointed | 2025-01-06 |
| Jon Olsen | Chief Executive Officer | Terminated | 2025-01-06 |
| Jon Olsen | member of the board of directors | Resigned | 2025-01-06 |
| Samer Kaba | Chief Medical Officer | Resigned | 2024-12-23 |
| Greg Lipschitz | Executive Chairman | Appointed | 2024-12-03 |
| David Johnson | director of the board of directors of the Company | Resigned | 2024-12-03 |
| David Johnson | Executive Chairman | Resigned | 2024-12-03 |
| Stella Vnook | Director | Appointed | 2024-08-20 |
| David Johnson | Executive Chairman of the Board | Appointed | 2024-08-20 |
| Greg Lipschitz | director of the Board | Appointed | 2024-08-12 |
| Samer Kaba | Chief Medical Officer | Appointed | 2024-08-12 |
| Arun Menawat | director of the Board | Appointed | 2024-08-12 |
| Jon Olsen | director of the Board | Appointed | 2024-08-12 |
| Brian Posner | director of the Board | Appointed | 2024-08-12 |
| Bonnie K. Wachtel | member of the WaveDancer Board | Resigned | 2024-08-12 |